Qian Zhang | Nano-Biomedical Engineering | Best Researcher Award

Published on by Academic Awards

Assoc. Prof. Dr. Qian Zhang | Nano-Biomedical Engineering | Best Researcher Award

Shanghai Jiao Tong University | China

Assoc. Prof. Dr. Qian Zhang is an accomplished nanomedicine researcher based at Shanghai Jiao Tong University, specializing in the synthesis, surface modification, and biomedical applications of colloidal and magnetic nanomaterials. She earned her Doctor of Science from Philipps-Universität Marburg under Prof. Wolfgang Parak and holds Master’s and Bachelor’s degrees from Sichuan Agriculture University and Qingdao Agriculture University, respectively. Assoc. Prof. Dr. Qian Zhang’s career trajectory includes postdoctoral research, assistant and associate researcher roles at SJTU, and a visiting scientist position at the Weizmann Institute of Science in Israel. Her research focuses on the design of drug delivery systems integrating diagnosis and treatment, interaction of nanomaterials with cancer cells, and physico-chemical characterization of metal-doped magnetic nanomaterials for MRI applications. She has successfully led multiple national and Shanghai-based research projects, including studies on ferromanganese-based nanocarriers for ferroptosis induction and immunotherapy, heat-induced hybrid iron oxide nanocarriers combined with siRNA for early cancer diagnosis, and urine exosomal drug delivery systems for prostate cancer treatment. Assoc. Prof. Dr. Qian Zhang has authored two influential books and 68 publications in high-impact journals, accruing 4,842 citations with an h-index of 29, reflecting her strong scientific influence. Her work demonstrates remarkable innovation, translational relevance, and international collaboration, establishing her as a leading figure in nanomedicine and targeted cancer therapy.

Profile: Scopus

Featured Publications

Zhang, Q. (2026). Element-doped ferrite nanoparticles: From magnetic property tuning to biomedical applications. Coordination Chemistry Reviews, 548, 217151.

Zhao, Y., Zhang, Q., Zhang, A., Pan, S., Cheng, J., Ning, J., … Wang, C. (2025). A novel near-infrared AP-M@AntiACLY detection probe based on SERS to trace detection of serum ACLY for early diagnosis of pediatric sepsis. Sensors and Actuators B: Chemical.

Jin, Y., Huang, J., Tang, Y., Li, Z., Zhang, A., Yang, Z., … Zhang, Q. (2024). Boosting ferroptosis by intervention of redox balance and synergetic with photothermal/photodynamic therapy for suppression of pancreatic cancer. Chemical Engineering Journal, 497.

[Author(s) not fully listed]. (2024). Flower-shaped magnetic fluorescent nanoparticles based lateral flow biosensor for highly sensitive detection of cardiac troponin I. Sensors and Actuators B: Chemical.

[Author(s) not fully listed]. (2024). An ingestible near-infrared fluorescence capsule endoscopy for specific gastrointestinal diagnoses. Biosensors and Bioelectronics.

 

Pedro Fonte | Nanomedicine | Best Researcher Award

Published on by Academic Awards

Assist. Prof. Dr. Pedro Fonte | Nanomedicine | Best Researcher Award

Assist. Prof. Dr. Pedro Fonte, Faculty of Sciences and Technology, University of Algarve, Portugal

Assist. Prof. Dr. Pedro Fonte is a distinguished researcher in pharmaceutical technology and nanomedicine. He earned his PhD in Pharmaceutical Sciences – Nanotechnologies from the University of Porto and the University of Copenhagen in 2016, supported by an FCT scholarship. He is currently an Assistant Professor at the University of Algarve and leads the Biomaterials and Nanomedicine Lab at CCMAR and iBB, IST–ULisboa. With over 63 peer-reviewed publications, 11 book chapters, and an h-index of 31, he has been recognized among the Top 2% Scientists globally by Stanford University/Elsevier since 2021. His research focuses on nanocarrier-based drug delivery systems, having mentored numerous PhD and postdoctoral researchers. He previously held academic and leadership positions at Lusófona University and has contributed to international scientific bodies, including COST and the Science Fund of Serbia. Dr. Fonte is also an editor and author of several scientific books and experimental protocols in his field.

Publication Profile

Scopus

Orcid

Academic Background

Assist. Prof. Dr. Pedro Fonte has a strong multidisciplinary academic background, integrating pharmaceutical sciences, nanotechnology, and business management. He earned his PhD in Pharmaceutical Sciences – Nanotechnologies in 2016 from the Faculty of Pharmacy, University of Porto (Portugal), and the Faculty of Health and Medical Sciences, University of Copenhagen (Denmark), under the supervision of Drs. Bruno Sarmento, Salette Reis, and Marco van de Weert. His thesis, titled “Optimization of lyophilization parameters of polymeric nanoparticles for delivery of therapeutic proteins,” was completed with distinction and supported by an FCT scholarship (SFRH/BD/78127/2011). In 2012, he obtained an MBA in Business Management and Administration from Lusíada University, Porto, with a classification of 15 values. Prior to this, he completed an Integrated Master in Pharmaceutical Sciences in 2010 and a Bachelor’s degree in the same field in 2009 at the Advanced Institute of Health Sciences – North, CESPU, Gandra-Prd, Portugal, with classifications of 15 and 14 values, respectively.

Professional Journey

Assist. Prof. Dr. Pedro Fonte has established a distinguished academic and research career in biomaterials and nanomedicine. Since October 2019, he has served as Assistant Professor at the University of Algarve and Group Leader at Fonte’s Lab, affiliated with CCMAR and iBB, both recognized research units in Portugal. He is also an integrated member of CCMAR and a collaborating researcher at iBB. Previously, Dr. Fonte held positions at Lusófona University, including Assistant Professor, Director of the Biomedical Nanoscience Lab, and Group Leader in Biomaterials. He was also affiliated with LAQV/REQUIMTE and UCIBIO/REQUIMTE, both classified as excellent R&D units. His doctoral studies spanned institutions like the University of Porto, University of Copenhagen, and University of Lisbon, supported by FCT grants. Earlier in his career, he undertook multiple internships and fellowships in hospital, community pharmacy, and clinical labs, laying the groundwork for his pioneering work in nanomedicine and drug delivery.

Teaching and Pedagogical Contributions

Prof. Pedro Fonte has made remarkable contributions to academic development through the creation and dissemination of high-quality pedagogical materials in pharmaceutical technology and nanomedicine. His scholarly dedication is evident in the authorship of 11 textbook publications and 4 detailed experimental protocols, which serve as valuable resources for students and researchers alike. He has also contributed 7 encyclopaedia entries and 4 insightful articles to magazines and newsletters, enhancing public and academic understanding of complex scientific topics. Embracing modern educational tools, Prof. Fonte has developed 5 computer applications and 3 experimental prototypes that support interactive learning and research. Furthermore, he has produced a wide array of teaching materials tailored to various educational levels and contexts. His pedagogical work reflects a deep commitment to fostering learning through innovative and accessible content, positioning him as a key academic figure in advancing education in pharmaceutical sciences and nanomedicine across national and international platforms.

Research Focus

Prof. Pedro Fonte’s research is centered on advanced drug delivery systems, with a particular emphasis on nanotechnology, biomaterials, and biopharmaceuticals. His work spans a diverse range of applications, including wound healing, cancer therapy, tuberculosis treatment, and oral and inhalable delivery of therapeutic proteins and peptides. He has made substantial contributions to the development of nanoparticle-based systems, such as PLGA nanoparticles, mesoporous silica carriers, and lipid-based nanostructures, aimed at enhancing the stability, targeting, and bioavailability of drugs. His recent publications highlight innovations in freeze-drying of biopharmaceuticals, mucoadhesive systems, and nanonutraceuticals. Prof. Fonte also explores the biomedical application of sustainable materials like carbon dots in imaging and treatment, demonstrating a strong commitment to translational research. His multidisciplinary collaborations and editorial contributions to high-impact journals and books further emphasize his leading role in pharmaceutical nanotechnology and the development of next-generation therapeutics for chronic and infectious diseases

Publication Top Notes

  • Delivery of therapeutic proteins for wound healing (book chapter, 2024) –ScienceDirect+9OUCI+9cienciavitae.pt+9

  • Drug delivery systems for mouth wound healing (book chapter, 2024) – cienciavitae.pt+1ResearchGate+1

  • Unravelling the drying techniques of protein biopharmaceuticals (book chapter, 2024) –cienciavitae.pt+1ResearchGate+1

  • Inhalable N‑Acetylcysteine‑loaded Lactose‑coated PLGA Nanoparticles for Tuberculosis Treatment (Journal article, 2025) 

  • Impact of chain‑length of sulfhydryl‑modified surface‑decorated surfactants on mucoadhesive nanostructured lipid carriers (Journal article, 2025)

  • Recent advances in antibacterial nanoformulations for endodontic applications (Journal article, 2025) 

  • Camptothecin‑loaded mesoporous silica nanoparticles… skin cancer treatment (Journal article, 2024) 

  • Transforming cancer treatment: The potential of nanonutraceuticals (Journal article, 2024) 

 

 

Erick Ondari | Bio Nanotechnology | Best Researcher Award

Published on by Academic Awards

Dr. Erick Ondari | Bio Nanotechnology | Best Researcher Award

Dr. Erick Ondari, Kisii University, Kenya

Dr. Erick Nyakundi Ondari, Ph.D., is a distinguished Kenyan researcher and Senior Lecturer at Kisii University, serving as Head of the Department of Biological Sciences. With a strong academic foundation in Biotechnology from Karpagam University, India, Dr. Ondari has cultivated interdisciplinary expertise in nanotechnology, bioinformatics, molecular biology, and natural product research. He has actively contributed to scientific knowledge through impactful publications, global conference presentations, and collaborative research projects, including co-PI roles in multimillion-shilling grants on cervical cancer screening and COVID-19 vaccine development. His work in mechanistic nanoparticle research and phytochemical therapeutics has earned him multiple international honors, including awards from conferences in Thailand, India, and Uganda. Dr. Ondari’s mentoring excellence is evident through his students’ success in securing prestigious fellowships and travel grants. A peer reviewer for top-tier journals, he also contributes to curriculum development and policy advisory roles in Kenyan and East African institutions. Committed to public health outreach, he has led sensitization programs on HIV/AIDS and substance abuse. His technical skills range from flow cytometry to nanomaterial synthesis, backed by certifications in good clinical and laboratory practices, ethics, and bioinformatics. Dr. Ondari is a dynamic force in African STEM advancement, combining research innovation, leadership, and community service with exceptional professionalism.

Publication Profile

Orcid

Google Scholar

🎓 Educational Background

Dr. Erick Ondari has pursued a comprehensive and interdisciplinary academic journey in the life sciences, particularly in the fields of biotechnology and bioinformatics. He earned his Ph.D. in Biotechnology from Karpagam University, India (2012–2016), focusing on the mechanistic characterization of Tridax procumbens-mediated silver nanoparticles as novel nanocides against Anopheles stephensi. Prior to this, he completed his Master of Science in Biotechnology at AVS College of Arts & Sciences, Periyar University (2009–2011), where his thesis involved amplification of the emm gene to confirm drug resistance in Streptococcus pyogenes in the Salem District. His academic foundation began with a Bachelor’s degree in Biotechnology (2006–2009) from KSR College of Arts & Sciences, where he researched the isolation and characterization of Actinomycetes with antibiotic properties. Additionally, Dr. Ondari pursued two postgraduate diplomas at Bharathiar University: one in Chemi-informatics (2011–2012), focused on molecular modeling and docking of the DAP gene from Streptococcus suis and S. parauberis, and another in Bioinformatics (2010–2011), centered on annotating non-coding regions of Streptococci species. His foundational education includes a KCSE from Sameta Boys High School (2005) and KCPE from Sironga D.E.B Primary School (2001), marking the beginning of a distinguished academic and research career.

📘 Professional and Work Experience

Dr. Erick Nyakundi Ondari has amassed a diverse and impactful professional background in academia and research across East Africa and India. Currently, he serves as a Senior Lecturer and Head of the Department of Biological Sciences at Kisii University’s School of Pure and Applied Sciences, a position he has held since June 2023. He has been a Lecturer at Kisii University since September 2017, contributing to both undergraduate and postgraduate teaching and research. From 2018 to 2022, Dr. Ondari was a Visiting Lecturer at Kampala International University – Western Campus, Uganda, where he also served as Head of the Biochemistry Department (2020–2021) and Postgraduate Coordinator (2022). Prior to this, he worked as a Full-Time Lecturer at Kampala International University in Dar-es-Salaam, Tanzania (2017–2018). His earlier teaching roles include Part-Time Lecturer positions at JKUAT-Kisii Campus, Kisii University, and Africa Nazarene University. Dr. Ondari’s research journey began in India, where he was a Research Scholar at Karpagam University (2012–2015) and a Research Assistant under the University Grants Commission at Bharathiar University (2011–2012). This extensive cross-border academic experience underscores his commitment to education, research, and capacity building in molecular sciences and biotechnology across the region.

🏅 Honors, Grants, and Consultancies

Dr. Erick Ondari has been consistently recognized for his outstanding contributions to biotechnology and health sciences through numerous honors, grants, and consultancies. Notably, he secured an AGNES-Alexander Humboldt Stiftung Travel Grant for his student in 2024 and served as a Guest Speaker at the 2023 International Conference on Trends in Biological Sciences in India, where he presented on “Nanotechnology in Health.” He actively participated in the AfriLSc RNA Salon Symposium and presented groundbreaking research on schistosomiasis diagnostics at an international nursing conference. In 2023, Dr. Ondari received the Best Poster Presentation Award at the Uganda Virus Research Institute symposium. His students have also flourished under his mentorship, winning travel grants to prestigious events like the IBRO World Congress of Neuroscience in Spain. In 2022, he guided a Ph.D. student awarded a DBT-UNESCO-TWAS fellowship for tuberculosis research. As Co-Principal Investigator, he secured a KShs 50 million grant for cervical cancer screening innovations in Kenya and was instrumental in obtaining a multi-million Ugandan Shillings grant for COVID-19 vaccine development with Makerere University. Dr. Ondari also participated in the H3ABioNet IBT Course for bioinformatics, showcasing his commitment to capacity-building and translational research across Africa

🔬 Research Focus

Dr. Erick Ondari’s research is firmly rooted in interdisciplinary biosciences, with a strong emphasis on biotechnology, nanotechnology, bioinformatics, and natural product research. His work predominantly addresses vector control and antimicrobial resistance through the innovative application of green nanotechnology, as demonstrated in his highly cited paper on the optimization of silver nanoparticles for targeting Anopheles stephensi, a malaria vector. His research integrates molecular physiology and nanobiotechnology, focusing on the synthesis, characterization, and biological evaluation of biogenic nanoparticles for mosquitocidal and antimicrobial activity. Dr. Ondari’s contributions to computational biology are evident through molecular modeling and docking studies aimed at understanding protein-ligand interactions in pathogens like Streptococcus suis, Streptococcus parauberis, and Pneumocystis jiroveci. His bioinformatics work on annotating non-coding genomic regions and studying antimicrobial agents from natural phytochemicals underscores his commitment to addressing pressing public health challenges using eco-friendly and precision-based scientific methods. His multidisciplinary expertise positions him within the emerging fields of environmental nanoscience, phytochemical drug discovery, and computational toxicology, making significant impacts on both human health and environmental safety. Dr. Ondari’s research profile aligns well with modern global scientific priorities, especially in neglected tropical diseases, biomedical innovation, and bio-nano interface technologies.

Publication Top Notes

📄 Green chemistry focus on optimization of silver nanoparticles… – Cited by 56 (2015) 🧪🦟
📄 Antimicrobial activity of biogenic silver nanoparticles synthesized using Tridax procumbens L – Cited by 25 (2014) 🌿🧬
📄 Effect of biopolymer stabilized silver nanoparticles on antioxidant genes… – Cited by 6 (2017) 🧫🧠
📄 Annotation of non-coding regions of streptococci family: A case study – Cited by 2 (2013) 🧬🧠
📄 Larvicidal and pupicidal effect of Tridax procumbens mediated synthesis of silver nanoparticles… – Cited by 1 (2014) 🦟🌱
📄 Synthetic Biology Industrial Revolution, Social And Ethical Concerns – Not cited (2019) ⚙️🌍
📄 Molecular modeling and docking studies of dihydrodipicolinate reductase enzyme… – Not cited (2014) 💻🧪
📄 Secondary metabolites from Annona squamosa as a potential antimicrobial agent – Not cited (2014) 🍃🧫
📄 Molecular modeling approach and RMSD calibration for superimposed 3D structure… – Not cited (2014) 🧠🖥️

Ehsan Kianfar | Nano | Best Researcher Award

Published on by Academic Awards

Dr. Ehsan Kianfar | Nano | Best Researcher Award

Ehsan Kianfar at Islamic Azad University, Gachsaran, Iran.

Dr. Ehsan Kianfer is a dedicated chemical engineering researcher from Iran, with a passion for catalysis, nanotechnology, and membrane science. Known for his innovative work on zeolite catalysts and vanadium oxide nanostructures, he has contributed extensively to both academic and industrial applications. His work spans multiple international conferences, journals, and patent achievements. As a committed academic and reviewer, Dr. Kianfer plays an active role in scientific communities, mentoring students and contributing to research excellence. His publications, teaching experience, and recognitions reflect a career driven by innovation, collaboration, and excellence in engineering and applied sciences.

Publication Profile

Google Scholar

Scopus

Academic Background

Dr. Kianfer earned his Ph.D. in Chemical Engineering from Islamic Azad University, Arak, Iran, graduating with an impressive GPA of 19.88/20. His doctoral thesis focused on the preparation and identification of zeolite catalysts for methanol-to-gasoline and ethylene-to-propylene conversions. He also completed his M.Sc. in Chemical Engineering at the same university with a thesis on vanadium oxide nanostructures using hydrothermal and ultrasonic methods, and a GPA of 17.32/20. His education includes international certifications in management systems (PCMS) from Australia, showcasing a strong foundation in both scientific knowledge and professional best practices.

Professional Background

Dr. Kianfer brings a wealth of research, academic, and editorial experience to the field of chemical engineering. He has worked extensively on membrane performance with nanoparticle integration, and has conducted experimental studies on CO₂ absorption using hollow fiber membrane contactors. With over a decade of teaching experience in thermodynamics, fluid mechanics, and chemical process engineering at Islamic Azad University, he has also served as a referee and editor for multiple international journals. Additionally, he leads research projects, contributes to scientific associations, and collaborates with global scholars in developing innovative technologies for energy and environment.

Awards and Honors

Dr. Kianfer has been recognized with numerous accolades, including Best Article at the Second National Conference on Process Engineering in 2013 🏆, and dual honors as Best Referee and Top Researcher at an international engineering conference in Turkey, 2016 🌍. He has also served as a reviewer for top-tier journals and international conferences in countries like Spain, Malaysia, and Iran. His consistent excellence in peer review and scholarly contribution has earned him respect and visibility within the global scientific community, validating his position as a leader and innovator in chemical engineering and nanotechnology research.

Research Focus

Dr. Kianfer’s research centers on catalyst science, separation membranes, and nanoparticle synthesis 🔬. His work explores the development of zeolite catalysts for fuel production, membrane performance enhancement through nanomaterials, and the biomedical applications of nanoparticles and biosensors. With publications in biosensor development for lung cancer detection and membrane technologies for gas separation, his research spans energy, environment, and health sectors. He also holds a patent on nanoparticle synthesis for water treatment and gas separation membranes, underscoring his contributions to sustainable engineering solutions and applied nanoscience across both academic and industrial domains.

Publication Top Notes

Nano-Based Drug Delivery in Cancer: Tumor Tissue Characteristics and Targeting
Year: 2023
Cited by: 3 citations 📄

Nanomaterial by sol‐gel method: synthesis and application

Nano Biosensors: properties, applications and Electrochemical Techniques

Protein nanoparticles in drug delivery: Animal protein, Plant proteins and protein cages, Albumin nanoparticles

Magnetic Nanoparticles in Targeted Drug Delivery: a Review

Zeolite-based Catalysts for Methanol to Gasoline process: A review

Ionic liquids: properties, application, and synthesis

Polyethylene terephthalate (PET) recycling: A review

Methods of chemical synthesis in the synthesis of nanomaterial and nanoparticles by the chemical deposition method: a review

Recent advances in synthesis, properties, and applications of vanadium oxide nanotube

Conclusion

Dr. Ehsan Kianfer is a highly accomplished researcher and educator in Chemical Engineering, specializing in nanotechnology, catalysis, and membrane science. With a Ph.D. in Chemical Engineering and an exceptional GPA of 19.88/20, his research has focused on sustainable energy solutions, catalyst development, and advanced membrane technologies. His extensive academic and professional contributions include numerous published papers in prestigious journals, two authored books, and several awards, including Best Article and Top Researcher honors. Dr. Kianfer’s active participation in global scientific communities, along with his patent in gas separation membranes, further highlights his innovation and industry impact. His consistent excellence in teaching and mentoring further solidifies his qualifications, making him a strong candidate for the Best Researcher Award.

 

Areen Alshweiat | Nanotechnology | Best Researcher Award

Published on by Academic Awards

Assist. Prof. Dr. Areen Alshweiat | Nanotechnology | Best Researcher Award

Assist. Prof. Dr. Areen Alshweiat, The Hashemite University, Jordan

Assist. Prof. Dr. Areen Alshweiat is a dedicated pharmaceutical scientist at The Hashemite University, Jordan 🇯🇴. She earned her PhD from the University of Szeged, Hungary, specializing in the development of loratadine nanosystems for intranasal delivery using a Quality by Design approach 🎓. Dr. Alshweiat’s expertise spans nanoparticle formulation, smart crystals, electrospinning nanofibers, and nose-to-brain drug delivery 💊🧬. She has authored numerous publications in top journals, focusing on innovative drug delivery systems and bioavailability enhancement. Currently, she serves as the Head of the Department of Pharmaceutics and Pharmaceutical Technology and contributes to regulatory committees at the Jordan Food and Drug Administration 📚🔬.

 

Publication Profile

Google scholar

Academic Qualifications

 

Assist. Prof. Dr. Areen Alshweiat holds a distinguished academic background in pharmaceutical sciences. She completed her PhD at the Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Hungary 🇭🇺, where she focused on the “Development and Characterization of Loratadine Nanosystems for Intranasal Delivery Using Quality by Design Approach” 💊. Prior to this, she obtained her Master’s degree in Pharmaceutical Technology from Jordan University of Science and Technology (JUST), with a thesis on the “Preparation and Evaluation of Tacrolimus Solid Dispersion Systems” 🧬. She also holds a Bachelor’s degree in Pharmacy from JUST, graduating in 2009 🎓.

Professional Experience

Assist. Prof. Dr. Areen Alshweiat has an extensive background in pharmaceutical sciences, having worked across various esteemed institutions 🌍. She contributed to the Interdisciplinary Centre of Excellence in Hungary, focusing on the development of novel drug-carrier systems (2018-2020) 💊. She also engaged in a project at the University of Edinburgh, Scotland, exploring nanofibers for drug delivery in 2019 🧪. At The Hashemite University, Jordan, she served as a full-time lecturer (2015-2016) and currently holds the role of Assistant Professor and Head of the Department of Pharmaceutics and Pharmaceutical Technology (2020-Present) 🏛️. Additionally, she is a member of the Post Approval Changes and Generic Drugs Registration Committees at the Jordan Food and Drug Administration (2024-Present) 🏥.

Research Interests

Assist. Prof. Dr. Areen Alshweiat’s research focuses on advanced pharmaceutics and pharmaceutical technology 💊. Her expertise spans formulation development, including innovative drug delivery systems like nanoparticles and SmartCrystals 🌟. She has a keen interest in electrospinning nanofibers for enhanced drug delivery applications 🧪. Dr. Alshweiat is particularly dedicated to exploring targeted drug delivery methods, emphasizing intranasal and nose-to-brain delivery systems for improved therapeutic outcomes 🧠. Her work aims to optimize the effectiveness and precision of pharmaceutical formulations, addressing complex drug delivery challenges with cutting-edge techniques 🚀.

Publication Top Notes

  • Intranasal nanoparticulate systems as alternative route of drug delivery 🧠📄 – A Alshweiat, R Ambrus, II Csóka, Current Medicinal Chemistry, cited by 81 (2019)
  • Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine 🌿💊 – A Alshweiat et al., International Journal of Pharmaceutics, cited by 58 (2020)
  • Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation 🌊🔬 – A Alshweiat et al., European Journal of Pharmaceutical Sciences, cited by 58 (2018)
  • 3D-printed electrospinning setup for the preparation of loratadine nanofibers 🧵🖨️ – R Ambrus, A Alshweiat et al., International Journal of Pharmaceutics, cited by 31 (2019)
  • SmartCrystals for efficient dissolution of poorly water-soluble meloxicam 🌟💧 – R Ambrus, A Alshweiat et al., Pharmaceutics, cited by 14 (2022)
  • Flavonoid-based nanomedicines to target tumor microenvironment 🌱🧬 – WH Talib, A Alshweiat et al., OpenNano, cited by 12 (2022)
  • QbD based control strategy of loratadine nanosuspensions and dry nanoparticles stabilized by Soluplus® 🛠️📊 – A Alshweiat et al., Farmacia, cited by 10 (2019)
  • In vivo tests of a novel wound dressing based on agar aerogel 🩹🧫 – T Athamneh, A Alshweiat et al., International Journal of Biological Macromolecules, cited by 8 (2023)
  • Antibiofilm and antimicrobial activity of chitosan-polyacrylic acid nanoparticles 🦠🔬 – A Alshweiat et al., Saudi Pharmaceutical Journal, cited by 6 (2024)
  • Recent insights into nanoformulation delivery systems of flavonoids against glioblastoma 🧠🩸 – A Alshweiat et al., Journal of Drug Delivery Science and Technology, cited by 3 (2023)